{"SPADE_UN_09511": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2002/0111305 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2002_0111305_A1", "Patent Type": "Patent Application", "Publication Date": "2008-1-1", "Family Info": "CA2353530A1,EP1147132A2,WO2000032629A2,WO2000032629A3", "Patent Title": "Antiviral peptides.", "Abstract": "The invention relates to peptides for use as antiviral agent, consisting of an amino acid chain which contains a domain of 10 to 25 amino acids, wherein the majority of the amino acids of the one half of the domain are positively charged amino acids and the majority of the amino acids of the other half of the domain are uncharged amino acids. The invention further relates to oligomers of these peptides consisting of at least two such peptides which are coupled to each other, optionally via a spacer, for use as antiviral agent, in addition to the use of the peptides and/or oligomers for the manufacture of a medicine for treating viral infections."}], "Sequence Information": {"SPADE ID": "SPADE_UN_09511", "Sequence": "KRLFKELKFSLRKYKRLFKELKFSLRKYK", "Sequence Length": 29, "Peptide Name": "Sequence 17 from Patent US 20020111305", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "KLF", "Absent Amino Acids": "ACDGHIMNOPQTUVW", "Basic Residues": 13, "Acidic Residues": 2, "Hydrophobic Residues": 12, "Polar Residues": 17, "Positive Residues": 13, "Negative Residues": 2, "Mass": 3822.68, "PI": 10.88, "Net Charge": 11, "Hydrophobicity": -1.04, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_09503", "Similarity": 1.0, "Sequence": "KRLFKELKFSLRKY"}, {"SPADE_ID": "SPADE_UN_09512", "Similarity": 0.9310344827586207, "Sequence": "KRLFKKLKFSLRKYKRLFKKLKFSLRKYK"}, {"SPADE_ID": "SPADE_N_08489", "Similarity": 0.9285714285714286, "Sequence": "KRLFKKLLKFSLRKY"}]}}}